16-Jun-2010 - The role of the pharma industry in supporting the COE anti-counterfeiting treaty, which aims to criminalise activities, “cannot be underestimated”, according to a directorate member.
15-Jun-2010 - BioScale has secured $25m (€21m) to fund commercialisation of its ViBE protein analytics systems.
10-Jun-2010 - Water used by pharmaceutical manufacturing facilities is being released into the environment with drug concentrations that are up to 1000 times higher than normal according to a study conducted by the US Geological Survey (USGS).
08-Jun-2010 - KV Pharmaceuticals has decided to cut its losses and sell its subsidiary Particle Dynamics in a deal worth $24.6m (€20.6m). The deal adds some much needed stability as the business attempts to shore up its finances during a difficult period.
07-Jun-2010 - Caraco’s work plan setting out remedial actions needed to restart production at its Detroit-based plant has been approved by the FDA.
03-Jun-2010 - An anti-counterfeiting pilot project in Nigeria, which uses a mobile authentication service (MAS) to validate genuine medication, has completed a 100-day pilot phase. Preliminary results suggest the scheme is well on the way to becoming an effective defence against counterfeit drugs and other products.
03-Jun-2010 - American chemicals maker Cambrex has announced its active pharmaceutical ingredient (API) manufacturing facility has completed a successful FDA inspection.
03-Jun-2010 - The USP is strengthening links with Eastern Europe and Russia by agreeing to share quality standards with Ukraine and offering training courses in Moscow.
02-Jun-2010 - Indian-based drug makers continue to come under intense scrutiny by the US Food and Drug Administration (FDA) as the regulatory body issues warnings to healthcare professionals not to use certain brands of antibiotics due to potential contamination.
25-May-2010 - US biotech Genzyme will pay $175m and cease some manufacturing operations at its facility in Allston, Massachusetts under final terms of Food and Drug Administration (FDA) consent decree.
20-May-2010 - The US FDA should change its disclosure policy relating to manufacturing site inspections according to new draft recommendations by the Department of Health and Human Services (HHS) Transparency taskforce.
20-May-2010 - Eisai has opened a $100m (€81m), 65,000 sq ft commercial manufacturing and drug development site for intravenous treatments in Research Triangle Park (RTP), North Carolina, US.
19-May-2010 - India and Thailand have requested the WHO ends its involvement with IMPACT, which the countries believe has conflicts of interest, and begin a programme focused on quality, safety and efficacy.
18-May-2010 - Concerns about the quality and capabilities of Baxter’s manufacturing operations have led to Halozyme issuing a notice of breach and stating it may terminate their Hylenex relationship.
12-May-2010 - The IFMPA says that patients are the real victims of counterfeiters and has asked drugmakers to put this at the heart of their fight against fakers.
06-May-2010 - Healthcare major Johnson & Johnson (J&J) has suspended operations at a Pennsylvania plant linked to a major product recall after US FDA inspection.
05-May-2010 - KV Pharmaceutical has reported that an independent expert has re-inspected its facility and found it to be in compliance with good manufacturing practices (GMP).
03-May-2010 - The Office of the United States Trade Representative (USTR) has expressed particular concern about the proliferation of counterfeit drugs in countries including Brazil, China, India, Indonesia and Russia.
28-Apr-2010 - Manufacturing problems at Mitsubishi Tanabe Pharma (MTP) have forced CEO Michihiro Tsuchiya to relinquish his vice presidency of the Japanese Pharmaceutical Manufacturers Association (JPMA).
27-Apr-2010 - The USP and FDA must work to identify counterfeited or intentionally adulterated products before they enter the healthcare system by collaborating on the modification of monographs, according to Margaret Hamburg.
22-Apr-2010 - Delegates lucky enough to have made the trip to Interphex 2010 in New York, US bore witness to the launch of a wide range of new drug manufacturing technologies with products by O'Hara, Corning and PTI being some of the highlights.
19-Apr-2010 - in-PharmaTechnologist presents exclusive interactive maps of pharma manufacturing facilities in India, detailing the number of bulk drug and formulation facilities in each region of the country.
19-Apr-2010 - More Dewas-related problems for Ranbaxy as the Indian generic drugmaker recalls an antibiotic in the US.
15-Apr-2010 - GE Sensing and Inspection Technologies has introduced an logger capable of covering a temperature range from -85ºC to 140ºC to provide a single tool for a variety of applications.
06-Apr-2010 - The Chinese SFDA has found that four batches of rabies vaccine produced by Jiangsu Yanshen contained insufficient quantities of API and is investigating the conduct of some employees, according to Simcere.